Tata Motors Ltd (NSE:TAMO) is set to acquire Italian truck manufacturer Iveco (BIT:IVG) for $4.5 billion from the Agnelli family’s investment firm Exor (AS:EXOR), according to the Economic Times. The deal marks Tata’s largest automotive acquisition since its $2.3 billion purchase of Jaguar Land Rover in 2008 and will be executed through a Dutch entity owned by Tata Motors.
The boards of Tata Motors and Iveco are expected to meet Wednesday to approve the transaction. As part of the agreement, Tata plans to buy Exor’s 27.1% stake in Iveco and launch a tender offer for the remaining shares, excluding Iveco’s defense division. Iveco separately confirmed it is in advanced discussions with multiple parties regarding potential deals for its defense and commercial vehicle businesses.
The acquisition underscores Tata Motors’ aggressive global expansion strategy in the commercial vehicle sector. Iveco, a prominent European truck maker, would significantly strengthen Tata’s international footprint and provide synergies in manufacturing and technology.
Morgan Stanley and Goldman Sachs are advising on the transaction. Once finalized, this deal will rank as Tata Group’s second-biggest acquisition overall, following its landmark Corus Steel buyout.
The move reflects growing consolidation in the global automotive industry as companies seek scale and diversified markets amid rising costs and evolving clean energy regulations.


Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Anta Sports Expands Global Footprint With Strategic Puma Stake
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Samsung Electronics Shares Jump on HBM4 Mass Production Report
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 



